Meiyuan Dong

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglin Xu, Song Wen, Min Gong, Meiyuan Dong, Yue Yuan, Yanyan Li, Mingyue Zhou, Ligang Zhou
The Implication of Elevated Serum Myoglobin Level in Acute Diabetic Complications of Ketoacidosis and Hyperglycemic Hyperosmolar State: A Real-World Study. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Chenglin Xu, Song Wen, Min Gong, Meiyuan Dong, Yue Yuan, Yanyan Li, Mingyue Zhou, Ligang Zhou
The Implication of Elevated Serum Myoglobin Level in Acute Diabetic Complications of Ketoacidosis and Hyperglycemic Hyperosmolar State: A Real-World Study. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Xiaojing Huang, Huiling Chen, Song Wen, Meiyuan Dong, Ligang Zhou, Xinlu Yuan
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xiaojing Huang, Huiling Chen, Song Wen, Meiyuan Dong, Ligang Zhou, Xinlu Yuan
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Huiling Chen, Xiaojing Huang, Meiyuan Dong, Song Wen, Ligang Zhou, Xinlu Yuan
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xiucai Li, Song Wen, Meiyuan Dong, Yue Yuan, Min Gong, Congcong Wang, Xinlu Yuan, Jianlan Jin, Mingyue Zhou, Ligang Zhou
The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Meiyuan Dong, Huiling Chen, Song Wen, Yue Yuan, Liling Yang, Yanyan Li, Xinlu Yuan, Dongxiang Xu, Ligang Zhou
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Meiyuan Dong, Huiling Chen, Song Wen, Yue Yuan, Liling Yang, Dongxiang Xu, Ligang Zhou
The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Meiyuan Dong, Huiling Chen, Song Wen, Yue Yuan, Liling Yang, Dongxiang Xu, Ligang Zhou
The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Meiyuan Dong, Huiling Chen, Song Wen, Yue Yuan, Liling Yang, Yanyan Li, Xinlu Yuan, Dongxiang Xu, Ligang Zhou
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Meiyuan Dong, Song Wen, Ligang Zhou
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)